278 related articles for article (PubMed ID: 2388647)
1. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
Vaamonde J; Luquin MR; Obeso JA
Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
[TBL] [Abstract][Full Text] [Related]
2. Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation.
Stocchi F; Ruggieri S; Brughitta G; Agnoli A
J Neural Transm Suppl; 1986; 22():209-18. PubMed ID: 3465872
[TBL] [Abstract][Full Text] [Related]
3. [Continuous dopaminergic stimulation in Parkinson disease].
Obeso JA; Luquin MR; Vaamonde J; Grandas F; Pastor MA; Artieda J; Martínez-Lage JM
Neurologia; 1987; 2(5):227-34. PubMed ID: 2908545
[No Abstract] [Full Text] [Related]
4. Continuous lisuride effects on central dopaminergic mechanisms in Parkinson's disease.
Baronti F; Mouradian MM; Davis TL; Giuffra M; Brughitta G; Conant KE; Chase TN
Ann Neurol; 1992 Dec; 32(6):776-81. PubMed ID: 1471868
[TBL] [Abstract][Full Text] [Related]
5. [Orally administered lisuride in the treatment of complex fluctuations of motion in Parkinson disease].
Luquín MR; Obeso JA; Vaamonde J; Martínez Lage JM
Neurologia; 1989 Sep; 4(7):229-32. PubMed ID: 2638588
[TBL] [Abstract][Full Text] [Related]
6. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
Stocchi F; Ruggieri S; Antonini A; Baronti F; Brughitta G; Bellantuono P; Bravi D; Agnoli A
J Neural Transm Suppl; 1988; 27():27-33. PubMed ID: 3165437
[TBL] [Abstract][Full Text] [Related]
8. Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.
Nyholm D; Constantinescu R; Holmberg B; Dizdar N; Askmark H
Acta Neurol Scand; 2009 May; 119(5):345-8. PubMed ID: 18822087
[TBL] [Abstract][Full Text] [Related]
9. Apomorphine and lisuride infusion. A comparative chronic study.
Stocchi F; Bramante L; Monge A; Viselli F; Baronti F; Stefano E; Ruggieri S
Adv Neurol; 1993; 60():653-5. PubMed ID: 8420205
[No Abstract] [Full Text] [Related]
10. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges.
Katzenschlager R; Hughes A; Evans A; Manson AJ; Hoffman M; Swinn L; Watt H; Bhatia K; Quinn N; Lees AJ
Mov Disord; 2005 Feb; 20(2):151-7. PubMed ID: 15390035
[TBL] [Abstract][Full Text] [Related]
11. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
Bittkau S; Przuntek H
J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
[TBL] [Abstract][Full Text] [Related]
12. Intravenous lisuride corrects oscillations of motor performance in Parkinson's disease.
Obeso JA; Luquin MR; Martínez Lage JM
Ann Neurol; 1986 Jan; 19(1):31-5. PubMed ID: 3947037
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Parkinson's disease with subcutaneous lisuride infusions.
Fernandez Pardal M; Micheli F; Gatto M; Perez y Gonzalez N
J Neural Transm Suppl; 1988; 27():75-84. PubMed ID: 2969954
[TBL] [Abstract][Full Text] [Related]
14. [Subcutaneous administration of apomorphine in motor fluctuations in Parkinson's disease].
Pollak P; Champay AS; Gaio JM; Hommel M; Benabid AL; Perret J
Rev Neurol (Paris); 1990; 146(2):116-22. PubMed ID: 2320817
[TBL] [Abstract][Full Text] [Related]
15. [Sublingual administration of apomorphine in the treatment of motor fluctuations in Parkinson disease].
Durif F; Deffond D; Eschalier A; Tournilhac M
Rev Neurol (Paris); 1992; 148(10):610-4. PubMed ID: 1295055
[TBL] [Abstract][Full Text] [Related]
16. Continuous dopaminergic stimulation in Parkinson's disease.
Obeso JA; Luquin MR; Vaamonde J; Grandas F; Martinez Lage JM
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):488-92. PubMed ID: 3676922
[TBL] [Abstract][Full Text] [Related]
17. Continuous apomorphine infusion and neuropsychiatric disorders: a controlled study in patients with advanced Parkinson's disease.
Di Rosa AE; Epifanio A; Antonini A; Stocchi F; Martino G; Di Blasi L; Tetto A; Basile G; Imbesi D; La Spina P; Di Raimondo G; Morgante L
Neurol Sci; 2003 Oct; 24(3):174-5. PubMed ID: 14598073
[TBL] [Abstract][Full Text] [Related]
18. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
Manson AJ; Turner K; Lees AJ
Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
Stocchi F; Ruggieri S; Vacca L; Olanow CW
Brain; 2002 Sep; 125(Pt 9):2058-66. PubMed ID: 12183351
[TBL] [Abstract][Full Text] [Related]
20. Continuous dopaminergic stimulation in the management of complicated Parkinson's disease.
Agnoli A; Stocchi F; Carta A; Antonini A; Bragoni M; Ruggieri SA
Mt Sinai J Med; 1988 Jan; 55(1):62-6. PubMed ID: 3258057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
